Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis

Gómez‐Bañuelos, E., Shi, J., Wang, H., Danila, M. I., Bridges, S. L., Giles, J. T., Sims, G. P., Andrade, F., & Darrah, E. (2022). Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis. Arthritis & Rheumatology, 74(11), 1746–1754. Portico. https://doi.org/10.1002/art.42262

Authors:

E Gómez-Bañuelos

J Shi

H Wang

M I Danila

S L Bridges

J T Giles

G P Sims

F Andrade

E Darrah

Affiliated Authors:

J T Giles